What's in Eagle Pharmaceuticals, Inc.'s pipeline?

Eagle Pharmaceuticals, Inc. has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Eagle Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Astellas Pharma Inc, Bayer, CuraSen Therapeutics, Inc., Eli Lilly and Company, Hoffmann-La Roche.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/eagle-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Eagle Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Eagle Pharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ryanodex and Standard of Care	Ryanodex and Standard of Care	phase 3	Ryanodine receptor antagonist	Ryanodine receptor (RyR1)	Anesthesiology / Critical Care

Therapeutic area mix

Anesthesiology / Critical Care · 1
Inflammation · 1
Musculoskeletal · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Astellas Pharma Inc · 1 shared drug class
Bayer · 1 shared drug class
CuraSen Therapeutics, Inc. · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Eagle Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Eagle Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/eagle-pharmaceuticals-inc. Accessed 2026-06-10.